Hickinbottom v. Atrium Medical Corporation

CourtDistrict Court, D. New Hampshire
DecidedAugust 28, 2019
Docket1:17-cv-00713
StatusUnknown

This text of Hickinbottom v. Atrium Medical Corporation (Hickinbottom v. Atrium Medical Corporation) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hickinbottom v. Atrium Medical Corporation, (D.N.H. 2019).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Juanita Hickinbottom

v. Civil No. 17-cv-713-LM Opinion No. 2019 DNH 138 Atrium Medical Corp., et al.

In re: Atrium Medical Corp. MDL No. 2753 C-QUR Mesh Products Liability Litigation

O R D E R Juanita Hickinbottom brings suit against Atrium Medical Corporation (“Atrium”), a medical device company that manufactured and sold C-QUR mesh, and two related companies, Maquet Cardiovascular US Sales, LLC (“Maquet”) and Getinge AB (“Getinge”), alleging product liability claims, breach of warranty claims, and violation of consumer protection laws. Hickinbottom’s suit is part of a multi-district litigation (“MDL”) proceeding involving claims that C-QUR mesh was, among other things, defective and unreasonably dangerous and caused injury when surgically implanted for hernia repair. Her case was selected in the MDL proceeding for the Initial Discovery Pool, making it a bellwether case. Defendants Atrium and Maquet move to dismiss Hickinbottom’s claims on a variety of grounds.1 Hickinbottom objects.

1 Getinge has filed a separate motion to dismiss in the main MDL case contending that the court lacks personal jurisdiction over it. That motion remains pending. Getinge does not join in the instant motion. STANDARD OF REVIEW Under Rule 12(b)(6), the court must accept the factual allegations in the complaint as true, construe reasonable inferences in the plaintiff’s favor, and “determine whether the factual allegations in the plaintiff’s complaint set forth a plausible claim upon which relief may be granted.” Foley v. Wells Fargo Bank, N.A., 772 F.3d 63, 71 (1st Cir. 2014) (internal quotation

marks omitted). A claim is facially plausible “when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009).

BACKGROUND Hickinbottom had a laparoscopic procedure to repair a hernia on August 15, 2013 at Baptist Memorial Hospital (“Baptist Memorial”) in Oxford, Mississippi. A piece of C-QUR Mosaic mesh was used for the repair. Because of abdominal pain, she had “revisional surgery” on October 17, 2013 at Baptist Memorial, during which stitches were removed, abdominal wall

scarring was noted, and the wounds were irrigated. Atrium, which designed, marketed, and sold the C-QUR mesh that was implanted into Hickinbottom, is located in New Hampshire. Maquet is located in New Jersey, and Getinge is a Swedish corporation. Hickinbottom alleges that Maquet and Getinge are responsible for Atrium’s actions and exercised control over Atrium with respect to oversight and compliance with applicable safety standards. Hickinbottom alleges, among other things, that defendants designed, manufactured, marketed, and sold C-QUR mesh to be used by surgeons for hernia repair. C-QUR mesh was intended to be permanently implanted for those repairs, and defendants represented that C-QUR mesh was safe and effective for that purpose. Hickinbottom further alleges that C-QUR mesh was not safe or effective for its intended purpose, that defendants failed to adequately research and test it to determine the risks and benefits of the mesh, and that they failed to warn of risks although they had been notified that the mesh was causing widespread catastrophic complications. Hickinbottom brings claims for negligence (Count I), strict liability – design

defect (Count II), strict liability – manufacturing defect (Count III), strict liability – failure to warn (Count IV), breach of express warranty (Count V), breach of implied warranties of merchantability and fitness of purpose (Count VI), and violation of consumer protection laws (Count VII). She seeks compensatory and enhanced compensatory damages.

DISCUSSION Defendants Atrium and Maquet move to dismiss Hickinbottom’s claims, other than the violation of consumer protection laws claim in Count VII, as time-barred under the applicable statutes of limitations.2 They also argue that Mississippi law governs the liability portions of

Hickinbottom’s claims and that her claims fail under the applicable law. Hickinbottom objects, arguing that her claims are not time-barred, and that New Hampshire law governs the liability portions of her claims.

2 Defendants state in their memorandum in support of their motion to dismiss that “all of Plaintiff’s claims are time barred under the applicable statute of limitations and should be dismissed with prejudice.” Doc. no. 67-1 at 2. But they make no mention of Hickinbottom’s consumer protection claim in the section of their memorandum devoted to their statute of limitations argument. See id. at 3-7. Indeed, that section is titled “Plaintiff’s Negligence, Strict Liability, And Breach of Warranty Claims Are Time-Barred.” Id. at 3. Therefore, the court does not address the statute of limitations as to Count VII. I. Statute of Limitations The parties agree that New Hampshire’s statutes of limitations, as procedural rules of the forum state, apply in this case. See TIG Ins. Co. v. EIFlow Ins. Ltd., No. 14-cv-459-JL, 2015 WL 5714686, at *3 (D.N.H. Sept. 29, 2015) (discussing circumstances under which it is appropriate for this court sitting in diversity to apply New Hampshire’s statute of limitations).

They further agree that Hickinbottom’s product liability claims, Counts I through IV, are governed by RSA 508:4, I, and the breach of warranty claims, Counts V and VI, are governed by RSA 382-A:2-725.

A. Product Liability Claims Under New Hampshire law, “[e]xcept as otherwise provided by law, all personal actions, . . . may be brought only within 3 years of the act or omission complained of.” RSA 508:4, I. An exception to that time limit exists when the injury and its causal relationship to the act or omission were not discovered and could not reasonably have been discovered at the time of the act or omission, the action shall be commenced within 3 years of the time the plaintiff discovers, or in the exercise of reasonable diligence should have discovered, the injury and its causal relationship to the act or omission complained of.

RSA 508:4, I. If the defendant meets the initial burden of showing that the action was not brought within three years of the underlying events, to avoid dismissal, the plaintiff must show that the discovery rule or another tolling doctrine, such as the fraudulent concealment rule, applies. Beane v. Dana S. Beane & Co., P.C., 160 N.H. 708, 712 (2010). “[T]he fraudulent concealment rule states that when facts essential to the cause of action are fraudulently concealed, the statute of limitations is tolled until the plaintiff has discovered such facts or could have done so in the exercise of reasonable diligence.” Bricker v. Putnam, 128 N.H. 162, 165 (1986). The equitable purpose of the fraudulent concealment rule in tolling the limitations period is to prevent the wrongdoer from receiving and keeping the benefit of its fraudulent conduct. Lakeman v. LaFrance, 102 N.H. 300, 303 (1959). Similarly, the doctrine of equitable tolling delays the limitations deadline when the plaintiff “was prevented in some extraordinary way from exercising his or her rights.” Portsmouth Country Club v. Town of

Greenland, 152 N.H. 617, 623 (2005). Defendants argue that Hickinbottom’s product liability claims are time-barred because Hickinbottom had the mesh implanted in August 2013, had revision surgery two months later in October 2013, and did not bring suit until December 12, 2017, more than three years later. In response, Hickinbottom invokes the protection of the discovery rule and the doctrines of fraudulent concealment and equitable tolling.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Rodi v. Southern New England School of Law
389 F.3d 5 (First Circuit, 2004)
Lockheed Martin Corp. v. RFI Supply, Inc.
440 F.3d 549 (First Circuit, 2006)
Lakeman v. LaFrance
156 A.2d 123 (Supreme Court of New Hampshire, 1959)
Beane v. Dana S. Beane & Co., P.C.
7 A.3d 1284 (Supreme Court of New Hampshire, 2010)
SIG Arms Inc. v. Employers Insurance of Wausau
122 F. Supp. 2d 255 (D. New Hampshire, 2000)
Foley v. Wells Fargo Bank, N.A.
772 F.3d 63 (First Circuit, 2014)
Reggie Elliott v. El Paso Corporation
181 So. 3d 263 (Mississippi Supreme Court, 2015)
DeGrandis v. Children's Hospital Boston
806 F.3d 13 (First Circuit, 2015)
Bricker v. Putnam
512 A.2d 1094 (Supreme Court of New Hampshire, 1986)
Portsmouth Country Club v. Town of Greenland
883 A.2d 298 (Supreme Court of New Hampshire, 2005)
Kelleher v. Marvin Lumber & Cedar Co.
891 A.2d 477 (Supreme Court of New Hampshire, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Hickinbottom v. Atrium Medical Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hickinbottom-v-atrium-medical-corporation-nhd-2019.